Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
– Sell
-187,128
Closed -$60M – 8506
2017
Q3
$60M Buy
187,128
+80,633
+76% +$25.8M 0.03% 532
2017
Q2
$33.7M Buy
106,495
+41,635
+64% +$12.4M 0.02% 754
2017
Q1
$16.1M Buy
64,860
+3,669
+6% +$884K 0.01% 1166
2016
Q4
$13.7M Buy
61,191
+1,574
+3% +$342K 0.01% 1277
2016
Q3
$13.4M Sell
59,617
-11,528
-16% -$2.59M 0.01% 1215
2016
Q2
$16.7M Sell
71,145
-17,941
-20% -$3.9M 0.01% 1048
2016
Q1
$18.1M Sell
89,086
-11,949
-12% -$2.25M 0.01% 957
2015
Q4
$19.1M Buy
101,035
+4,229
+4% +$792K 0.01% 985
2015
Q3
$18M Buy
96,806
+8,521
+10% +$1.61M 0.01% 963
2015
Q2
$15.1M Sell
88,285
-19,469
-18% -$3.33M 0.01% 1169
2015
Q1
$18M Buy
107,754
+33,883
+46% +$5.81M 0.01% 1037
2014
Q4
$12.3M Sell
73,871
-3,742
-5% -$605K 0.01% 1348
2014
Q3
$11.1M Buy
77,613
+11,201
+17% +$1.65M 0.01% 1379
2014
Q2
$9.5M Sell
66,412
-5,130
-7% -$733K 0.01% 1415
2014
Q1
$10.6M Buy
71,542
+1,164
+2% +$161K 0.01% 1225
2013
Q4
$9.43M Sell
70,378
-18,348
-21% -$2.42M 0.01% 1299
2013
Q3
$10.2M Buy
88,726
+17,464
+25% +$2M 0.01% 1118
2013
Q2
$7.74M Hold
71,262
– – 0.01% 1236

Other funds holding BCR

UBS Group's BCR Position: Q4 2017 in Review

UBS Group sold out of CR Bard (BCR) in Q4 2017, closing a stake of 187,128 shares — an estimated $60M sold.

UBS Group first reported a position in BCR in Q2 2013 and held it in 18 quarters. The position peaked at $60M in Q3 2017. 112 funds tracked by Wall St. Rank hold BCR as of Q4 2017.

  • UBS Group reported no remaining CR Bard position as of Q4 2017 after selling out during the quarter.
  • UBS Group sold 187,128 CR Bard shares in Q4 2017, an estimated $60M.
  • UBS Group first reported a position in CR Bard in Q2 2013 and held it in 18 quarters.
  • UBS Group's CR Bard position peaked at $60M in Q3 2017.
  • 112 funds tracked by Wall St. Rank held CR Bard as of Q4 2017.

Based on UBS Group's 13F filing for Q4 2017, filed 14 Feb 2018.